Hyloris announces FDA Acceptance Of New Drug Application for Maxigesic IV in Post-Operative Pain.
Hyloris Pharmaceuticals SA, a speciality biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that the U.S.…